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Abstract 
Sean Watford 
Building Bridges Between Toxicity Testing in the 21st Century and Regulatory Decision-
making Through Interactive Web Applications (Under the direction of Matthew Martin 
and Ivan Rusyn) 
  
            Risk assessments and regulations are informed largely from animal studies, which 
are low throughput, costly, and time consuming. Gathering toxicity data for decisions on 
the large number of chemicals manufactured and used in commerce is a difficult task for 
current goals in chemical testing and safety decisions. Alternative approaches include 
computer models informed by existing toxicity data and computational toxicology like 
high throughput screening (HTS). Aggregating the large quantity of data produced 
through alternative methods is a difficult task with large gaps between the analysis and 
interpretation. The United States Environmental Protection Agency’s (USEPA) 
Interactive Chemical Safety for Sustainability (iCSS) Dashboard project seeks to close 
the gap by enabling stakeholders, including decision-makers, to easily access and 
visualize computational toxicology data from USEPA’s Toxicity Forecaster (ToxCast) 
project. The iCSS Dashboard is a web application that allows users to subset both HTS 
assays and chemicals to a manageable set for clearer visualization of the data, so the data 
is more accessible for understanding how computational toxicology can be applied to 
meet current goals in toxicity testing, screening, and risk assessments for chemical safety 
decision-making. 
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Chapter 1 Literature Review of Computational Toxicology 
 
Purpose 
 Current risk assessments and regulatory decisions are based largely on toxicity 
data from clinical trials, epidemiological studies, and animal studies (Demchuk et al., 
2008; Houck & Kavlock, 2008). Human data from clinical trials and epidemiological 
studies are most relevant to humans, but are low throughput and do not provide insight on 
the mechanisms underlying toxicity (Cogliano et al., 2008). While animal studies are 
amenable to higher throughput, extrapolation to humans can confound results and leaves 
a degree of uncertainty (Demchuk et al., 2008; Houck & Kavlock, 2008).  
 With large numbers of chemicals being manufactured each year and limited 
existing toxicity data, current approaches are not meeting the requirements for data to 
support informed decision-making. With current advances in alternative models both in 
vitro and in silico provide novel avenues for estimating toxicity (Gibb, 2008).  
 Computational approaches to toxicology provide a method to fill data gaps by 
developing computer models to predict the toxicity of new chemicals (Rusyn & Daston, 
2010). Computational approaches have a significant impact on decision-making and 
decision support for toxicity of chemicals due to the inherent scalability from higher-
throughput methods. Computational approaches produce a large amount of data in 
relatively short amounts of time. The high-throughput achieved with in silico approaches 
provides more information and can even be used to identify possible mechanisms of 
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toxicity (Collins, Gray, & Bucher, 2008; Demchuk et al., 2008; Dix et al., 2007; Gibb, 
2008; Houck & Kavlock, 2008). Computational approaches
combine chemical information including physico-chemical and structural properties with 
in vivo and in vitro data, when available (Rusyn & Daston, 2010). For example, results 
from previous and ongoing traditional approaches, in vitro high-throughput screening 
(HTS) biochemical assays, and ultra high-throughput data from microarrays can be 
incorporated into computational approaches. Finally, existing computer models like 
chemical docking can also be incorporated to produce predictive toxicity models for 
preliminary decision-making and toxicity analysis of existing and unknown chemicals 
(Kirchmair et al., 2012).  
 
Data Sources 
Aggregated Computational Toxicity Reference (ACToR) 
 The Aggregated Computational Toxicity Reference (ACToR) is a United States 
Environmental Protection Agency (USEPA) project that includes databases and tools to 
access and analyze toxicity data. The ACToR project includes the ACToR database, 
Toxicity Reference database (ToxRefDB), and Toxicity Forecaster database 
(ToxCastDB) accessible through a web interface accessible at http://www.actor.epa.gov. 
The ACToR database a relational database adapted from the PubChem project where 
assay space and chemical space are linked through data. Currently data for over 500,000 
chemicals from over 500 data sources resides in ACToR (R. S. Judson et al., 2012). 
 ToxCastDB, a subset of ACToR, contains data outputs from USEPAs Toxicity 
Forecaster (ToxCast) project (R. S. Judson et al., 2012). ToxCast captures HTS data to 
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produce a predictive model for prioritization of chemicals based on aggregated 
performance across the assays (Dix et al., 2007; Kavlock, Austin, & Tice, 2009; Rusyn & 
Daston, 2010). ToxCast currently consists of two phases of testing comprising over 1800 
chemicals run across over 800 HTS assays ("EPA Releases Chemical Screening Data on 
1,800 Chemicals/Agency improves access to chemical data and announces ToxCast Data 
Challenges," 2013). All of the ToxCast chemicals, assays and data are stored in 
ToxCastDB. 
 ToxRefDB, which is another subset of ACToR database (R. S. Judson et al., 
2012), contains data from guideline in vivo studies incorporating data from sub chronic, 
chronic, developmental, and reproductive toxicity studies as well as cancer bioassays 
from rats, mice, and rabbits. ToxRefDB is used to supplement Toxicity Forecaster 
(ToxCast) project for validation and generate hypotheses for proposed mechanisms of 
toxicity (Martin, Judson, Reif, Kavlock, & Dix, 2009).  
Comparative Toxicogenomics Database (CTD) 
 The Comparative Toxicogenomics Database (CTD) contains literature linking 
chemicals to gene and protein interactions. The interactions are also linked to 
corresponding disease outcomes creating a network of literature mapping chemicals to 
genes and genes to diseases. The literature is manually entered into the database so 
literature supporting each relationship is clearly defined. CTD functions as a hypothesis-
generating tool focusing on environmental chemicals and their relationship to diseases 
(Davis et al., 2013; Davis et al., 2009; Mattingly, 2009).  
Carcinogenicity Potency Database (CPDB) 
 The Carcinogenicity Potency Database (CPDB) is a collection of positive and 
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negative chronic cancer studies ranging back to the 1950s. CPDB serves as a uniform 
resource to locate and compare results from a multitude of studies on over 1050 
chemicals. The aggregation of data in CPDB enables reporting of qualitative and 
quantitative information about the experiment, carcinogenic chemical ratios, associations 
between carcinogenic potency, and predictions of carcinogenicity in target organs across 
different species (Gold, Manley, Slone, Rohrbach, & Garfinkel, 2005; Gold et al., 1991).  
Chemical Effects in Biological Systems (CEBS) 
 The Chemical Effects in Biological Systems (CEBS) database integrates 
toxicogenomics and proteomics data with gross observations, clinical chemistry, and 
other measurements from experiments in animals, cell cultures, and humans. Currently 
data for over 27 studies is available for search through the CEBS web interface, 
accessible at http://www.niehs.nih.gov/research/resources/databases/cebs/, either by 
study conditions or subject responses with a goal of viewing integrated data to 
hypothesize mechanisms associated with the observed biological responses (Waters et al., 
2008).  
Distributed Structure-Searchable Toxicity (DSSTox) 
 The Distributed Structure-Searchable Toxicity (DSSTox) database aggregates 
chemical structure data with toxic effects. Chemical structure data can be used in 
structure activity relationship (SAR) models to predict chemical toxicity. DSSTox serves 
as a central resource for this type of information to improve upon current SAR models 
and to incorporate chemical structure information into other predictive toxicity models 
(Richard & Williams, 2002).  
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Models and Use of Computational Toxicology 
 Computational toxicology has been used in many fields for predictive modeling 
and to supplement and support traditional toxicology findings. Within drug development, 
HTS has been used to discover chemicals best suited to treat a previously identified target 
where many different compounds are run against the same assay (Houck & Kavlock, 
2008). Use of HTS assays for regulatory toxicity aims to discover or test known toxicity 
targets against chemicals in use (Gibb, 2008). HTS provides important mechanistic data 
to support postulated modes of action (MOA) (Houck & Kavlock, 2008; Rusyn & 
Daston, 2010) and molecular initiating events (MIE) to map out adverse outcome 
pathways (AOP). Below are summaries on models informed by computational toxicology 
including the USEPA’s ToxCast project and Toxicity Testing in the 21st Century (Tox21) 
that have provided HTS data on numerous chemicals of interest.  
Toxicity Forecaster (ToxCast) and Toxicity Testing in the 21st Century (Tox21) 
 The USEPA’s ToxCast project has now released two phases of HTS data on over 
1800 chemicals and over 800 assays providing chemical performance across assays at 
multiple concentrations ("EPA Releases Chemical Screening Data on 1,800 
Chemicals/Agency improves access to chemical data and announces ToxCast Data 
Challenges," 2013). The data is analyzed and fitted to a concentration-response four-
parameter hill curve where the chemical is either active or inactive based on the ability to 
fit a hill curve. To relay relative potency, concentration at half the maximum response 
(AC50) is reported. For a single chemical, different assays can be grouped together based 
on target pathway and weighted scoring for an overall toxicity prioritization index 
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(ToxPi) score can be calculated. Chemicals can then be prioritized based on ToxPi scores 
(Reif et al., 2013). Tox21 efforts are similar, but the chemical library is much larger 
consisting of over 10,000 chemicals across around 100 HTS assays (Gibb, 2008). For 
screening and regulatory purposes, toxicity of new chemicals can be predicted by using 
ToxCast and Tox21 data with QSAR and other structure related models (R. Judson et al., 
2013). 
Quantitative Structure Activity Relationship (QSAR) and Read-Across 
 Quantitative Structure Activity Relationship (QSAR) modeling uses congeneric 
chemicals to quantitatively predict properties and the biochemical activity of chemicals. 
Chemical analogs can be grouped together to highlight trends in similar qualitative and 
quantitative properties, even predicted properties from QSAR. The QSAR models 
associating one or many chemicals to certain toxic endpoints can be extended to assume 
the biochemical activity of a chemical with no toxicity data, this approach is called read-
across. A chemical with no known bioactivity can have predicted properties based on 
structure relationships to chemicals with a wealth of toxicity data. The chemical 
properties can be used to match a group of analogs, such that the analogs have certain 
toxic endpoints therefore inferring unknown chemical has the same toxic endpoints 
(Barratt, 2003; Cherkasov et al., 2014; Patlewicz et al., 2013; Tropsha, 2012). 
Physiologically-Based Pharmacokinetic (PBPK) Models 
 Physiologically-Based Pharmacokinetic (PBPK) models are compartmental 
models that attempt to predict adsorption, distribution, metabolism, and excretion 
(ADME) of chemicals from each of the compartments (or organs) of interest. PBPK 
models are used for the development of pharmaceuticals. PBPK models have also been 
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used in risk assessment and exposure models. Data from computational approaches can 
be used to develop and refine PBPK models and support different AOPs by defining 
specific MOA and MIE ultimately mapping to larger biological responses and disease. 
PBPK models are used in regulatory toxicology for predicting safe levels of exposure, 
and understanding metabolism and distribution of chemicals in living organisms 
(Andersen, 2003).  
Threshold of Toxicological Concern (TTC) 
 Thresholds of Toxicological Concern (TTC) were originally developed in the 
1980’s by the United States Food and Drug Administration (FDA) to establish safe levels 
of exposure to chemicals found in food products that have little to no toxicity data 
available. The TTC approach requires the unknown chemical’s structure to find analogs 
and determine safe exposure levels based on the analogs’ available toxicity data and the 
intake level of the unknown chemical. TTC is similar to read-across except outputs from 
TTC are generated through a decision tree that asks questions about the properties and 
exposure of each chemical. The output of the decision tree can be a toxicity endpoint 
along with a threshold, or require further information before any type of decision can be 
made (Kroes, Kleiner, & Renwick, 2005; Munro, Renwick, & Danielewska-Nikiel, 
2008). Since the development and use of TTC in food products, TTC models are being 
developed and considered for use in risk assessments of environmental chemicals 
(Dewhurst & Renwick, 2013).  
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Challenges 
 Although computational approaches to toxicology solve problems of throughput 
and time efficiency, the data needs even further extrapolation to humans than animal 
studies. Animal studies have been, and continue to be, instrumental in the discovery of 
disease targets, toxic endpoints, and reference doses for risk assessments. However, 
animals are not always sufficient to provide data relevant to humans (Ennever & Lave, 
2003). Mechanistic data from in vitro studies and computer models face the same 
criticism due to an even higher level of extrapolation from a single molecule, cell, or 
culture to a larger biological response or disease. 
 A wealth of data is being produced, and advanced statistical methods are available 
for analyzing the large datasets. The large uncertainty inherently associated with HTS 
due to the nature of reporting and result interpretation remains a challenge for the use of 
these data. Ultimately, the combination of human, animal, HTS, and computational data 
is extremely powerful.  
 Computational approaches to toxicology produce a wealth of heterogeneous data 
related to existing data across multiple disciplines. Proper access, storage, and 
management of the data are essential for analysis and incorporation into the approaches 
mentioned above. Currently, no one source of toxicity data exists due to the difficultly in 
developing and managing a data model to effectively capture and manage the large 
quantity of data along with the complex relationships between the data.  
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Current Work 
 The Chemical Safety for Sustainability (CSS) project is an interdivisional project 
at the USEPA aiming to improve how chemicals are evaluated. The Interactive Chemical 
Safety for Sustainability (iCSS) Dashboard is a web application that serves as a portal to 
access USEPAs ToxCast data. iCSS is currently a beta release providing access to all 
assay information including descriptions as well as chemical information and the 
summary hit calls of all chemicals across all the assays. The goal of iCSS is to facilitate 
the communication between scientists and regulators by creating an easier way to interact 
and visualize the data for interpretation.  
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Chapter 2 Introduction: Bridging the Gap 
 Computational toxicology approaches are not traditionally used for decision-
making due to the gap between analysis and interpretation of data for regulatory 
purposes. Through the CSS project, many efforts are being made to develop new models 
and incorporate computational data into existing models for decision support and new 
screening processes. A key goal of the project is to facilitate communication between 
different fields so that bridging the gap in understanding between different sources of 
data is easier. The Interactive Chemical Safety for Sustainability (iCSS) Dashboard 
project is key to achieving the CSS goals by providing a portal for easier access to data 
from the ToxCast project as well as tools to aid in understanding the analysis for 
interpretation.  
 Feedback obtained from ongoing discussions with USEPA program offices and 
stakeholders, including decision-makers, about ToxCast is consistent: the data is difficult 
to understand due to the quantity of data, lack of descriptions surrounding the assays, and 
lack of explanations and examples of how to interpret the results. iCSS addresses 
feedback by providing an interactive web application with modes allowing users to subset 
assays and chemicals independently based on descriptions surrounding each assay and 
chemical for a more manageable data set. The performance of each chemical across an 
assay is summarized into a single summary activity call. All the data supporting the 
activity call is not reported through iCSS but is available in the data files. Only reporting 
the summary activity calls dramatically reduces the amount of data a user must mine.
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 Interpretation of the data solely from the beta release is difficult because the 
Prioritization mode is not yet implemented. Ultimately, incorporating Toxicological 
Priority Index (ToxPi) into iCSS will allow aggregation of assays, so performance of a 
chemical across subsets of assays can be scored and compared for ranking. Ultimately, 
with continued development, iCSS will provide users a way to logically navigate large 
sets of data to gain insight into toxicity mechanisms of chemicals.  
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Chapter 3 Materials and Methods 
 
Dataset 
 The dataset for the beta release of iCSS is from the most recent release of 
ToxCast that includes 1858 chemicals and 821 assays. The chemicals are from ToxCast 
phases I and II and e1k. A custom database, iCSSDB, was created to meet the specific 
needs of the application. Summary hit calls including tested and modeled responses each 
as individual coordinate pairs; concentration at 50% maximum response (AC50); 
concentration at the maximum response (Emax); and hill curve parameters, bottom of 
curve (B), top of curve (T), and slope of curve (W) are accessible through iCSS.  The 
assay descriptions are from ToxCast Assay Annotation, an ontology surrounding the 
ToxCast assays and adapted from BioAssay Ontology (Phuong, 2014). Figure 1 is an 
example of the hierarchy used in ToxCast Assay Annotation to describe an assay and link 
a specific assay endpoint to a summary hit call. The chemical descriptors consist of 
general properties surrounding each chemical adapted from data in DSSTox. No 
documentation is currently accessible through the application for each assay annotation 
and chemical descriptor.  
 The iCSSDB is a MySQL relational database. Separate tables for chemicals and 
assays with a one-to-many relationship link to tables with descriptors: assay selection 
parameters and chemical selection parameters. An aggregate table with a chemical and 
assay pair linked to the summary hit calls, tested responses, modeled responses, and hill 
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curve fits. The database is a MyISAM storage engine, so there’s no foreign key links or 
transaction safety. The public facing database is read only. The data is accessible through 
the web application or through the 5 data services described in Table 1. 
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Figure 1 Assay, Assay Component, Assay Endpoint Example from ToxCast Assay 
Annotation 
 
Figure 1: Assay, Assay Component, Assay Endpoint Example from ToxCast Assay 
Annotation 
This figure describes the hierarchy to represent the ToxCast assays with an assay as the 
most generic descriptor to an assay component to an assay endpoint. An assay can have 
one to many assay components; an assay component can have one to two assay 
endpoints; and each assay endpoint and chemical has a summary hit call.   
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Frameworks 
 Sencha’s Ext JS 4.2.x is JavaScript-based framework used to develop the front-
end client. Ext JS 4.2.x provides standards for developing an application supporting a 
model view controller (MVC) architecture. MVC is a common architecture used for 
development of many different applications. Conceptually, the model is the data to be 
displayed through a view, and controllers that keep the model and views synchronized by 
managing interactions by the user through the view. More details about the MVC 
architecture specific to the front end are provided below in the first Architecture section 
and generically represented in Figure 3-A. 
 Zendframework 2.0 is a php framework that also utilizes MVC architecture. The 
middle-ware that brokers information from the backend database to the client via data 
services (Table 1) is provided through Zendframework 2.0. The data model is abstracted 
through an object relational mapper (ORM), and business logic is applied to the 
corresponding objects for efficient representation on the client.  
 
Architecture 
Front-End 
 The major base classes in Ext JS 4.2.x are Model, Store, Proxy, Component and 
Controller. The Model class stores one piece of data like a single assay or single 
chemical. Figure 2 provides an example of a model for an Assay Endpoint. A Store is a 
collection of Models and has built-in methods for manipulation of the Models within the 
Store like sort. Using master/slave communication, Models from the master Stores can be 
subset into slave Stores. Master/slave communication is a conceptual design where a 
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master object serves as the authoritative source and manages all aspects of corresponding 
slave objects. For example, the master Chemical Store has information for all 1858 
chemicals, but chemicals can be excluded from viewing forming a smaller subset of 
chemicals. A slave Chemical Store is created that only contains Models for the smaller 
subset of chemicals. The client only interacts directly with the view that has the slave 
store registered with it. As decisions are made for subsets of chemicals, the changes are 
first written to the master Store then the slave store is subsequently reloaded with the 
changes.  
 A Proxy manages how a Store is loaded with Models. Within the context of iCSS, 
the Proxy loads Models from locally stored data. Asynchronous JavaScript and XML 
(AJAX) calls are made by the Ext JS global AJAX method to data services, and the 
JavaScript Object Notation (JSON) response is stored locally within an object that is read 
into the store through custom load methods.  
 The Component class represents any type of visualization on the client like a grid 
or dropdown menu as an object that is instantiated on the client and mapped to hypertext 
markup language (HTML) that is rendered on the client screen. A user interacts with the 
data through the Component objects, and Controllers capture the interactions of the user. 
The interactions, like a click, are called events. Each event has a callback function that is 
fired once the event is triggered. A specific Controller is registered to a Component or 
Components listening to specific events and firing callbacks to appropriately update 
objects.  
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Figure 2 Assay Endpoint Model Example 
 
Figure 2: Assay Endpoint Model Example 
A model within the context of application architecture is different than a statistical model 
or any other model mentioned in the literature review. The example model in this figure 
is data for an Assay Endpoint represented in JavaScript Object Notation (JSON), a data 
format used for communication between the client and server. The data, or model, can 
then be used in a view for displaying within the client. In this example, the model is one 
row within the Assay Selection Grid.   
  
16 
Middle Ware 
 ZendFramework 2.0, similar to Sencha’s Ext JS, is an MVC architecture that 
populates a server side object model from the data model, which is the schema for 
iCSSDB. The abstraction from the data model to the object model is accomplished with 
Doctrine, an object relational mapper (ORM). Business logic, like paging, is applied to 
the result sets from the database to load the object model in an appropriate format for the 
client.  
 Communication between the frontend client and backend databases is 
accomplished through data services. Within the context of iCSS, data services are 
platform independent applications that respond to a request through a url and pass a 
JSON response to the requester. Table 1describes the available data services that load 
data for the application.  
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Figure 3 Software Architecture with Focus on Model View Controller Front-End 
 
Figure 3: Software Architecture with Focus on Model View Controller Front-End 
Model View Controller (MVC) architecture is an application design concept that 
separates the data from the visualization. (A) The basic architecture of the web 
application displayed as a flow from the backend databases to the middleware Zend 
Framework 2.0 (MVC architecture) to the frontend Sencha Ext JS (MVC architecture) to 
the client. (B) A model represents data for visualization. (C) A store aggregates a 
collection of models and performs specific actions requested from the client (view). (D) 
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The view is a graphic display of a model or store. (E) A controller listens to requests from 
views and performs a specific action. 
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Table 1 List of Data Services 
Name Example Parameters 
Assay 
Selection  
http://actor.epa.gov/dashboard/data-
service/data-
selection/index?page=1&itemsPerPage=4&fie
ld=analysis_direction&name=negative 
page 
parameter_field 
parameter_name 
parameter_value 
ItemsPerPage 
sort 
meta 
Chemical 
Selection  
http://actor.epa.gov/dashboard/data-
service/chemical-
selection/index?page=1&name=PISA&vMin
=0&vMax=555.5 
page 
parameter_field 
parameter_name 
parameter_value 
ItemsPerPage 
sort 
meta 
Assay 
Explorer  
http://actor.epa.gov/dashboard/data-
service/data-
explorer/index?itemsPerPage=10000&assay_
endpoint=ACEA_T47D_80hr_Positive&page
=1&activity_call=active 
page 
assay_endpoint 
activity_call 
ItemsPerPage 
sort 
meta 
Chemical 
Explorer  
http://actor.epa.gov/dashboard/data-
service/chemical-
explorer/index?itemsPerPage=10000&casrn=
100-01-6&page=1&activity_call=active 
page 
casrn 
activity_call 
ItemsPerPage 
sort 
meta 
Concentratio
n Response  
http://actor.epa.gov/dashboard/data-
service/conc-response/index?casrn=80-05-
7&assay_name=ATG_ERa_TRANS&page=1 
page 
casrn 
assay_name 
 
Table 1: List of Data Services 
The parameter descriptions and constraints are listed in Table 2.  
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Table 2 List of Data Service Parameters 
Parameter Description 
page 
Any number < 1 results in page 1 being 
provided. Any number > MaxPages results in 
MaxPage number being provided. If page is 
not in the query string, page 1 is provided 
parameter_field Any alphanumeric value is accepted. Note the space, comma and underscore 
parameter_name Any alphanumeric value is accepted. Note the space, comma and underscore 
parameter_value If vMin>vMax a 404 error is given 
ItemsPerPage You may request any number of items per page. The default is 25. 
sort The name of the column to be sorted [ASC|DESC] *case sensitive.  
meta If meta=1 is set, a list of data_id's will be the only thing returned. 
assay_endpoint Any alphanumeric value is accepted. Note the space, comma and underscore 
activity_call Any alphanumeric value is accepted. Note the space, comma and underscore. 
casrn Any alphanumeric value is accepted. Note the space, comma and underscore 
assay_name Any alphanumeric value is accepted. Note the space, comma and underscore 
 
Table 2: List of Data Service Parameters 
The data service parameters are appended to the base uniform resource locator (URL) of 
the data service for communication between the server and client.  
 
 
 
 
 
 
 
 
  
21 
Chapter 4 Results 
 
Interactive Chemical Safety for Sustainability (iCSS) Dashboard Beta Release 
 The beta release of the application is currently public and accessible at 
http://actor.epa.gov/dashboard. The beta release serves as a browser of the ToxCast 
assays and chemicals as well as the summary hit calls for each chemical across the 
assays. Chemicals and assays can be subsetted by annotations surrounding the assays and 
chemicals. Full assay descriptions as well as data from result sets with replicates, not only 
summary activity calls, are available in the ToxCast data files downloadable at 
http://www.epa.gov/ncct/toxcast/data.html.  
 Below, summaries of each mode and a specific use case are detailed. Most users 
only want to see the summary hit calls on either a single chemical or small subset of 
chemicals rather than looking at a single assay. The application does not follow a specific 
workflow, but the recommended first step is to identify a subset of assays for viewing 
summary activity calls by chemical within the Assay Selection mode because selecting a 
subset of assays first can significantly decrease the amount of data to view at once.  
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Home 
 Home mode is the default mode and serves as the landing page of iCSS where 
general information about the application as well as ToxCast and other resources like 
workshops and events (Figure 4-B). The link to the full ToxCast data (Figure 4-D) is also 
provided along with the email link (Figure 4-C) for questions and feedback. Currently no 
history is logged for the application so refreshing the page or closing the browser will 
provide the user with a new session and bring the user back to the Home mode clearing 
all previous actions.  
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Figure 4 Home Mode 
 
Figure 4: Home Mode  
Home mode is the default mode that serves as the landing page for the application. (A) A 
short video provides a high level overview of the major goals of the ToxCast project. 
Also provided are (B) links to information about stakeholder workshops and data 
challenges, the (C) email to contact the iCSS team for feedback and questions, and the 
(D) ToxCast data files download link.  
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Assay Selection 
 Assay Selection mode is the recommended first mode to access, although any 
mode is accessible because no set workflow is implemented. Assay selection provides a 
list of all of the assays with all of the assay descriptions from ToxCast Assay Annotation 
database. Subsets of assays are grouped by the descriptors. A single assay or an existing 
subset of assays can be selected, added to a current subset, or removed from a current 
subset. 
Use Case 
 To select only the estrogen assays, select the field, 
“intended_target_gene_symbol” from the first drop down menu (Figure 5-B). Next, type 
“ESR1” into the second drop down menu (Figure 5-C) and click “ESR1” to select the 
symbol of the gene. The result will be 17 assays all involved with the estrogen receptor. 
To select only the 17 assays, press the “Select Only” button (Figure 5-D). If a subset of 
assays already exists, and the 17 estrogen assays need to be added to the subset, then 
press the “Add to Selection” button (Figure 3-E). Ultimately, the numbers of assays that 
have been selected will be updated according to the button selected and the numbers will 
be reflected in both Chemical and Assay Selection modes as well as the green 
information bar just below the mode buttons at the top of the page (Figure 5-A). The 
updated selection can be seen by navigating to the Assay Explorer mode and viewing the 
currently selected assays in the Assays Only Grid on the left side of the page (Figure 7-
A).  
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Figure 5 Assay Selection Mode 
 
Figure 5: Assay Selection Mode 
(A) The green information bar displays the current mode, number of chemicals selected 
for a subset, and the number of assays selected for a subset, and has the “Export” button. 
(B) The drop down menu listing the higher level, parent assay annotations. (C) A second 
drop down menu listing the lower level, child assay annotations. The second drop down 
menu is populated with the child annotations of the parent selected from B. (D) The 
“Select Only” button subsets the current result set of assays. (E) The “Add to Selection” 
button adds the current result set of assays to the existing subset. 
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Chemical Selection 
 The Chemical Selection mode is very similar to the Assay Selection mode except 
this mode allows the user to select subsets of chemicals. Chemical descriptors from 
DSSTox are used to subset the chemicals just as the assay descriptions from ToxCast 
Assay Annotation database are used to subset the assays.  
Use Case 
 To select only the phenols from the full chemical set, first select 
“Chemical_Super_Category” from the first drop down menu (Figure 6-B). Next, type 
“phenol” into the next drop down menu (Figure 6-C) and click “phenol” to select the 
chemical super category. These selection parameters produce a result set of 95 chemicals 
that are phenols according to the “Chemical_Super_Category” criteria of a phenol. To 
create a subset of only the phenols, press the “Select Only” button. The green information 
bar at the top of the page (Figure 6-A) that also contains the assays selected information 
will update according to the selection of chemicals. The subset of chemicals will be 
reflected in the Chemical Explorer mode in the Chemicals Only Grid on the right hand 
side of the page (Figure 8-A). 
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Figure 6 Chemical Selection Mode 
 
Figure 6: Chemical Selection Mode 
(A) The green information bar displays the current mode, number of chemicals selected 
for a subset, and the number of assays selected for a subset, and has the “Export” button. 
(B) The drop down menu listing the higher level, parent chemical annotations. (C) A 
second drop down menu listing the lower level, child chemical annotations. The second 
drop down menu is populated with the child annotations of the parent selected from B. 
(D) The “Select Only” button subsets the current result set of chemicals. (E) The “Add to 
Selection” button adds the current result set of chemicals to the existing subset. 
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Assay Explorer 
 Assay Explorer mode allows the user to select a single assay from the Assays 
Only Grid (Figure 7-A) to populate the Assay Explorer Grid (Figure 7-B) with the 
summary hit calls for the selected assay across all the chemicals that have been subsetted 
in Chemical Selection mode (or all of the chemicals if no chemical subset has been 
selected). The Assays Only Grid is searchable and sortable by assay endpoint and is not 
case sensitive. Only the subset of assays, or all the assays if no subset was selected, 
appear in the Assays Only Grid. With the summary hit calls loaded into the Assay 
Explorer Grid, a row can be selected to draw the concentration response plot (Figure 7-C) 
for that particular chemical and assay summary hit call. The concentration response plots 
reflect the parameters used to draw the hill curve (B, T, W, AC50, Emax) provided in the 
Assay Explorer Grid along with individual points used to produce the modeled response. 
The units for all of the concentrations reported are micro-Molar (uM). Currently, the 
units are only available through the concentration response plots but will be added to the 
Assay Explorer and Chemical Explorer Grids in the coming updates. 
Use Case 
 Continuing with the subset of 17 estrogen assays along with 95 phenols from the 
above use cases, the user will only be able to choose one of the 17 assays from the 
Assays Only Grid. By clicking on the “ATG_ERa_TRANS” assay endpoint from the 
grid, the Assay Explorer Grid is populated with the summary hit calls for 
“ATG_Era_TRANS” across only the 95 phenols. Both inactive and active hit calls are 
populated, but only active hit calls are loaded if the checkbox on the top of the Assay 
Explorer Grid is checked. The Assay Explorer Grid is not searchable, but each column 
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can be sorted by clicking on the header of the column. By clicking the “CASRN” column 
on the summary hit call grid with the “actives only” checkbox checked, the rows are 
sorted ascending by CASRN. Selecting the second chemical, 4-Nonylphenol (CASRN 
104-40-5), the concentration response plot (Figure 7-C) is drawn below the summary hit 
call grid. The parameters to fit the model and reasoning for the active hit call can be seen 
in the concentration response plot that is drawn. The logAC50 value in the Assay 
Explorer Grid is mapped to the grid to see that within the modeled curve the logAC50 is 
0.84 uM. 
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Figure 7 Assay Explorer Mode 
 
Figure 7: Assay Explorer Mode 
(A) The Assays Only Grid displays only the subset of assays selected from Assay 
Selection mode. The grid is searchable and sortable by Assay Endpoint. (B) The Assay 
Explorer Grid displays summary hit calls across all chemicals from the chemical subset 
from Chemical Selection mode for a single assay that is selected from A. (C) The 
concentration response plot is drawn once a row from B is selected. 
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Chemical Explorer 
 Most users are interested in the performance of either a single chemical or a small 
subset of chemicals across the ToxCast assays. The Chemicals Only Grid (Figure 8-A) is 
searchable by either CASRN or chemical name and is not case sensitive. The 
recommended search is by CASRN since chemical names are not unique, but uniqueness 
of CASRN is preserved within the ToxCast chemicals. The CASRN search matches any 
CASRN within the subset of chemicals selected from Chemical Selection mode, but 
hyphens must be included in the search. For example, to find Bisphenol A (80-05-7) by 
CASRN “-05-”, “80-0”, or “80-05-7” will have Bisphenol A in the results; Alternatively, 
“8005” or “057” will not have Bisphenol A in the results. Searching by chemical name 
does not search synonyms, but only the exact chemical name within iCSSDB. With 
updates, the chemical search will include synonyms, including alternate CASRNs. Once a 
chemical is selected from the Chemicals Only Grid, the summary hit calls for the selected 
chemical across all of the assays or the subset of assays from the Assay Selection mode 
populate the Chemical Explorer Grid (Figure 8-B). Once a specific row from the 
Chemical Explorer Grid is selected, the concentration response plot (Figure 8-C) 
corresponding to the summary hit call is drawn below the Chemical Explorer Grid. 
Use Case 
 Using the subset of 17 estrogen assays and 95 phenols from the above Assay 
Selection mode and Chemical Selection mode use cases, within the Chemicals Only Grid 
in Chemical Explorer mode only the 95 phenols are visible. Each column, “CASRN” and 
“Chemical Name”, is searchable and sortable. Use the same chemical, 4-Nonylphenol, 
example from the previous use case on Assay Explorer mode. 4-Nonylphenol is found by 
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typing the CASRN “104-40-5” into the text box below the “CASRN” column header. 
Clicking on 4-Nonylphenol populates the Chemical Explorer Grid with the hit calls 
across the 17 estrogen assays selected from Assay Selection mode. To view only the 
assays that are active, check the “actives only” checkbox located within the header within 
the Chemical Explorer Grid. The grid is reloaded with 6 assays including 
“ATG_ERa_TRANS” from the Assay Explorer mode use case. Selecting 
“ATG_ERa_TRANS” will draw the same concentration response plot seen in the use 
case from Assay Explorer mode. The same fit parameters match the curve drawn for a 
simpler visualization of the hit call. 
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Figure 8 Chemical Explorer Mode 
 
Figure 8: Chemical Explorer Mode 
(A) The Chemicals Only Grid displays only the subset of chemicals selected from 
Chemical Selection mode. The grid is searchable and sortable by CASRN and chemical 
name. (B) The Chemical Explorer Grid displays summary hit calls across all assays from 
the assay subset from Assay Selection mode for a single chemical that is selected from A. 
(C) The concentration response plot is drawn once a row from B is selected. 
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Export 
The summary hit call data seen in both Assay Explorer Grid and Chemical Explorer Grid 
is available for export. When the “Export” button is clicked, the export prompt (Figure 9) 
is presented to the user before the data is generated and downloaded. The prompt informs 
the user of the number of chemicals and assays the export will contain. Once the user 
clicks the “OK” button, the file containing the summary hit calls for the subset of 
chemicals and subset of assays from Chemical Selection mode and Assay Selection mode 
respectively will be generated and downloaded to the client as a comma separated values 
(CSV) file. Table 3 contains a small excerpt from the export file generated from the 
above use cases.  
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Figure 9 Export Prompt 
 
Figure 9: Export Prompt 
The export prompt is shown after the “Export” button is clicked. The prompt displays the 
number of chemicals and assays within their respective subsets to inform the user exactly 
what the generated export file will contain. With a larger number of chemicals and 
assays, the export file will take a longer time to generate and download.  
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Table 3 Excerpt from Export of Summary Hit Calls of 95 Chemicals and 17 Assays 
Assay Endpoint Chemical Name CASRN 
Activity 
Call 
AC 
50 Emax Log AC 50 B T W 
ACEA_T47D_80hr_Po
sitive 
Sodium 
phenolate 139-02-6 Active 25.7 34.1 1.41 
0.1
87 35.8 1.84 
ACEA_T47D_80hr_Po
sitive 
2-Hydroxy-4-
methoxybenzop
henone 131-57-7 Inactive 1000 31.6 3 0 0 1 
ACEA_T47D_80hr_Po
sitive Phenolphthalin 81-90-3 Inactive 1000 11.1 3 0 0 1 
ACEA_T47D_80hr_Po
sitive 
3-tert-
Butylphenol 585-34-2 Inactive 1000 15.6 3 0 0 1 
ACEA_T47D_80hr_Po
sitive 
2,3,6-
Trimethylphenol 
2416-94-
6 Inactive 1000 6.48 3 0 0 1 
ACEA_T47D_80hr_Po
sitive 4-Phenylphenol 92-69-3 Active 8.31 110 0.92 
-
9.3
2 116 2.49 
ACEA_T47D_80hr_Po
sitive p-Cresol 106-44-5 Inactive 1000 15.7 3 0 0 1 
ACEA_T47D_80hr_Po
sitive Phenol 108-95-2 Inactive 1000 3.06 3 0 0 1 
ACEA_T47D_80hr_Po
sitive Thymol 89-83-8 Inactive 1000 8.19 3 0 0 1 
ACEA_T47D_80hr_Po
sitive 
tert-
Butylhydroquin
one 
1948-33-
0 Inactive 1000 7.89 3 0 0 1 
ACEA_T47D_80hr_Po
sitive 
2,3-
Dimethylphenol 526-75-0 Inactive 1000 18 3 0 0 1 
ACEA_T47D_80hr_Po
sitive 
4-(Butan-2-
yl)phenol 99-71-8 Active 9.68 118 0.986 
0.8
91 123 1.6 
ACEA_T47D_80hr_Po
sitive 
Butylated 
hydroxytoluene 128-37-0 Inactive 1000 3.88 3 0 0 1 
ACEA_T47D_80hr_Po
sitive Bisphenol B 77-40-7 Active 
0.23
9 152 -0.622 
-
0.3
24 140 2.32 
ACEA_T47D_80hr_Po
sitive 
2,5-Di-tert-
butylbenzene-
1,4-diol 88-58-4 Inactive 1000 13.4 3 0 0 1 
ACEA_T47D_80hr_Po
sitive Octylparaben 
1219-38-
1 Active 1.1 114 0.0409 
2.9
1 119 1 
ACEA_T47D_80hr_Po
sitive 
3,3?,5,5?-
Tetraiodothyroa
cetic acid 67-30-1 Inactive 1000 1.42 3 0 0 1 
ACEA_T47D_80hr_Po
sitive Octyl gallate 
1034-01-
1 Inactive 1000 4.84 3 0 0 1 
ACEA_T47D_80hr_Po
sitive 
Isopropyl-o-
cresol 499-75-2 Inactive 1000 12 3 0 0 1 
 
Table 3: Excerpt from Export of Summary Hit Calls of 95 Chemicals and 17 Assays 
The table is a very small excerpt from the export file generated after all steps from the 
use cases were taken. Columns excluded from this excerpt are Q and Data Type. Q is a 
qualifier that represents uncertainty surrounding the AC50 such as “less than” or 
“equals”. Data Type is the response unit and is either “Fold Induction” or “Percent 
Activity”. 
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Chapter 5 Discussion, Limitations, Conclusion, and Future Directions 
 
Discussion 
 Research in toxicology is being driven towards computational approaches because 
current goals in risk assessment and regulation are not being met by traditional methods 
in toxicology. Computational approaches produce large amounts of data in a short 
amount time, but large gaps exists between analysis and interpretation of data. Currently 
several large sources of computational toxicology data exists and are largely accessible 
through web applications. Although the data is accessible, criticism remains the same: too 
much data exists to mine and examples of how the data has been analyzed, can be used 
and subsequently interpreted are lacking. To further utilize computational data within 
regulations these concerns must be addressed. 
 Through continued, open communication with stakeholders and decision-makers, 
including USEPA program offices, feedback is being assessed to develop applications to 
meet the needs of all stakeholders wanting to use these data. The iCSS project 
incorporates feedback to facilitate the communication between interested groups for 
clearer interpretation of data from computational approaches to toxicology. The iCSS 
Dashboard is comprised of ToxCast data summarizing activity of over 1,800 chemicals 
across over 800 HTS assays. Through the four modes currently implemented in the beta 
release, users can subset assays and chemicals independently for a smaller, targeted, and 
manageable set of data. The concentration response plot across
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each chemical and assay intersection summarizes the activity with the parameters to fit a 
four-parameter hill curve. The summary hit calls for the subset of chemicals and assays 
can be exported for further review and serve as a reference when looking though the 
ToxCast data files for all the result sets with replicates.   
 ToxCast assays can be aggregated together into data classes to produce a 
biological read across model by scoring a chemical’s performance across each data class 
and ranking the chemicals. Using Toxicity Priority Index (ToxPi), data classes and the 
corresponding scores can be visualized for a clearer understanding of a chemical’s 
performance across specific subsets of assays. For example, estrogen, androgen, thyroid, 
and steroidogensis are data classes for ranking chemicals according to endocrine 
disruption potential. Each chemical can be scored across these data classes to be ranked 
based on individual endpoints (estrogenic, androgenic, thyrogenic, and/or steroidogenic) 
or collectively against all endpoints (overall endocrine disruption potential), which is the 
ToxPi score. Individually, the assays do not provide information about the overall 
toxicity endpoints, but aggregating the assays together in data classes provides a more 
holistic view of a chemicals behavior across specific toxicity pathways because each 
assay provides information about chemical performance across a snapshot of a toxicity 
pathway. Prioritization mode for iCSS, which is currently not implemented, would utilize 
data classes and ToxPi for biological read across using ToxCast assays and chemicals. 
 Implementing the prioritization mode, which is a key task mentioned in future 
directions, will allow users to incorporate computational toxicity data into chemical 
safety decisions. For example, using the endocrine disruption example above, the 
Endocrine Disruptor Screening Program (EDSP) could use biological read across to 
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expedite and support Tier 1 screening decisions, which identifies chemicals with the 
potential to be an endocrine disruptor. Information from the biological read across would 
also provide information for Tier 2 screening decisions, which identify a chemical’s 
specific endocrine disruption endpoints, by narrowing down the specific endocrine 
pathways that could possibly be affected to result in the endpoint. 
 Ultimately, implementing Prioritization mode will help translate chemical 
performance across assays to toxicity endpoints bridging the gap between analysis and 
interpretation of computational toxicity data because the large amount of data can be 
collectively quantified and visualized. With clearer interpretations of chemical 
performance combined with effective features to subset assays for aggregation into data 
classes, which is also a task mentioned in future directions, iCSS will become a more 
effective tool for hazard characterization for chemical safety decisions to increase the 
user base. Increasing the user base not only drives the development of the application 
through demand and feedback, but, also, helps validate ToxCast and any other data and 
models incorporated through updates and future versions. 
 
Limitations 
 The major limitations faced with the development and release of the beta version 
of iCSS surround user needs, data needs, and technological needs. Although user 
feedback from workshops promoting ToxCast and iCSS is positive, users are still having 
trouble navigating the application. Even with one-on-one sessions to answer specific 
questions, users are still confused about navigating the application as well as how the 
data can be used. Most of the feedback is about the lack of descriptions surrounding an 
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assay. Descriptions in sentence form are available through the data files, but currently, no 
sentence descriptions are available for each assay endpoint through iCSS. Documentation 
surrounding the data and how to use it is lacking and has contributed to the gap between 
analysis and interpretation of the data. Despite having annotations from ToxCast Assay 
Annotation available for each assay in Assay Selection mode, users have a difficult time 
interpreting the annotations because no documentation is provided through iCSS. For 
example, users have trouble understanding the difference between technological and 
intended targets. The technological target is the target being measured from the assay, 
and the intended target is the target that describes the biological process being captured. 
For example, the assay endpoint ATG_ERa_TRANS has a technological target of mRNA 
and an intended target of transcription factor with both targets mapped to the gene ESR1 
(gene id 2099). Both targets along with the gene effectively describe the biological 
process that is captured within the assay: measuring mRNA from transcription of the 
gene ESR1 describes transcription factor regulation of the gene ESR1.  
 Users have also commented that they are not able to use the application because 
iCSS cannot perform a specific function they need. For example, many users would like 
to export only the active summary hit calls for a subset of assays and chemicals. Also, 
users would like to export all the descriptions, or annotations, for a subset of assays and a 
subset of chemicals. The only export currently available is all of the summary hit calls for 
the subset of assays and subset of chemicals from Assay Selection and Chemical 
Selection modes.  
 iCSS is currently limited to only ToxCast data due to the difficulty in creating, 
updating, and managing a data schema built within a relational database. Incorporating 
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data from other sources like ToxRefDB would break the current schema for iCSSDB. 
Storing heterogeneous data within a schema is extremely difficult due to the inherent 
complexity of the data itself, but also the complex relationships between data from 
multiple sources. Other solutions for storing heterogeneous data are available, like graph 
databases that do not require a schema, but are currently not in use because of the time 
required to map existing data into an entirely new backend then rebuild the middleware 
for support to the client. 
 A technological need, along with alternative database solutions to support other 
data sources, is browser support for older versions of Mozilla Firefox and Internet 
Explorer. Currently, iCSS browser support is limited to only the most recent versions of 
Google Chrome and Mozilla Firefox. Developing a web application to work across all 
platforms is a huge task because the application needs to be compatible with the user 
base’s browsers including the correct version. Each browser uses JavaScript and styles in 
different ways, so development to meet all users’ needs is challenging.  
 
Conclusion 
 In conclusion, the development and release of iCSS is a significant step towards 
facilitating the communication between stakeholders interested in computational 
toxicology. Updates and development of newer versions will be driven by continued 
discussions with stakeholders to meet any needs required for improvements in chemical 
testing and safety decisions.  
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Future Directions 
 Through continued development driven by ongoing communication between 
stakeholders, including USEPA program offices and decision-makers, future versions 
will include a prioritization mode, data from other sources driving the development of a 
new schema or schema free solution, other features and tools to create a better user 
experience and effectively navigate the large amount of data, and documentation 
including examples detailing specific use cases for the application.  
 The first major step in development is implementing Prioritization mode. As 
mentioned in the discussion, Prioritization mode will incorporate data classes, aggregates 
of assays by toxicity pathways or endpoints, and ToxPi to score, rank, and visualize 
chemical performance across assays for clearer interpretation of the data.  
 Incorporating data from other sources like ToxRefDB Exposure Forecaster 
Database (ExpoCastDB) and ACToR requires a new schema for iCSSDB because the 
schema is currently specific to ToxCast data. Creating a schema to represent 
heterogeneous data is difficult because relationships between the data cannot be 
efficiently stored within a tabular structure. A new schema that captures all the data and 
relationships between the data and able to be quickly queried is needed to maintain 
usability of the application. Other solutions exist like graph databases, which do not have 
schemas and efficiently store extremely large amounts of data along with capturing 
complex relationships. The first goal is create a schema to support data from both 
ToxCast and ToxRef. A graph solution is further away because a specific graph database 
needs to be chosen, and the security review for external access to the database can take a 
long time.  
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 Other features currently in development are history support, user logs, better tools 
to navigate the data like 2D structure similarity search, and a more user-friendly 
interface. With history support, users can more effectively navigate the application by 
undoing actions. Currently, if the page is refreshed or the user clicks the back button, the 
application will restart losing all progress. History support will prevent any loss of 
progress or premature exiting of the application. User logs would save all the actions 
from a session and be available for export along with any other information from the 
application, so another user can replicate the process to observe the same data. Tools 
specific for navigating the assay space and chemical space are currently in development. 
For example, the 2D structure similarity search allows users to find chemicals of a similar 
structure to compare performance across assays. The new tools will be implemented in 
user friendly visualizations with interactions like drag-and-drop rather than large tables 
and drop down menus with basic interactions.  
 Lastly, further documentation surrounding ToxCast Assay Annotation and 
specific use cases are currently in progress. Sentence descriptions about the assays, 
currently available only through the ToxCast Data files, are being added as tooltips for 
consistent access to descriptions of assays in all modes. Both written and video examples 
of specific cases of how to accomplish specific tasks through iCSS are also in progress. 
All the documentation will be available through links on the Home mode.  
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Chapter 6 Practicum Report 
 In partial requirement for the Master of Science in Public Health, I completed my 
practicum at USEPA’s Office of Chemical Safety and Pollution Prevention, Office of 
Pollutions Prevention and Toxics, Information Management Division 
(USEPA/OCSPP/OPPT/IMD) under direction of Matthew Leopard, the director of IMD. 
The goal of the practicum was to work with members of OPPT involved with the Toxic 
Substances Control Act (TSCA) in order to expand my knowledge of risk 
characterization of chemicals. In order to look at data submitted to TSCA for risk 
characterization, I had to get clearance for Confidential Business Information (CBI). I 
was denied clearance because I was not a Federal employee, but I was still able to meet 
the competencies required for completion of the practicum requirement. Summarized 
below are descriptions of how each competency was met.   
 OPPT has a public web application called ChemView that allows users to search 
for data used to support toxicity endpoint decisions on a particular chemical. Due to my 
background and work on iCSS, I provided feedback on all aspects of the development of 
ChemView including how to improve the interface and incorporate other data into the 
application. I attended three meetings where these topics were addressed. The first 
meeting was a high level overview of the future directions of ChemView as well as a 
review of recent feedback from demonstrations with Division Directors within OPPT. I 
did not actively participate in discussions in this meeting, however, I learned a lot about 
the development of the ChemView. I also learned a lot about the data accessible through 
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ChemView, so I was able to participate in discussions in other meetings. The next 
meeting was with the contractors, who gave me a brief overview of the software 
architecture and then focused on how the data is displayed. Adding computational 
toxicology data is a high goal for ChemView, so I was able to talk to the developers 
about the use of computational toxicology data as well as how it relates to the toxicity 
data provided through ChemView, which is data from traditional toxicology approaches 
and/or environmental and ecotoxicology studies. The last meeting was with again with 
OPPT Division Directors and focused mainly on how to use computational toxicology 
data and how to incorporate it into ChemView. I was able to effectively communicate the 
use of ToxCast data to support risk characterizations of chemicals because of the 
knowledge gained through the other meetings as well through reading documentation 
detailing TSCA methodologies. Through these meetings I completed the Communication 
and Informatics, Diversity and Culture, and Leadership competencies. 
 I also met with scientists involved with the receipt and storage of data provided to 
TSCA. Through these meetings, I was given demos of the data available through 
ChemView and was walked through the various regulations and decisions placed on the 
chemicals. I was able to actively participate in the meetings with these scientists because 
I already had enough background knowledge to ask informed questions and the meetings 
were very relaxed. I was able to refer to documents detailing TSCA methodologies for 
questions, but also for discussion points on how challenges to the methodologies are 
being addressed. I met the environmental sciences and systems thinking competency by 
reviewing the TSCA program with these scientists. 
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Table 4 Competencies Met for Practicum 
Competency How to meet competency How Competency was Met 
Communication and 
Informatics 
Use information technology tools effectively in 
core public health functions such as retrieval of 
institutional and online public health data and 
dissemination of public health information 
Successfully used ChemView as a 
tool for accessing information 
surrounding a chemical’s toxic 
endpoint 
Engage in collective information sharing, 
discussion and problem solving Actively participated in meetings 
discussing data needs from different 
research programs for a more 
successful risk characterization 
process 
Diversity and 
Culture 
Show effective and productive skills in 
working with diverse individuals including co-
workers, partners, stakeholders, and/or clients 
Leadership 
Create a climate of trust, transparency, mutual 
cooperation, continuous learning, and openness 
for suggestion and input with co-workers, 
partners, other stakeholders, and/or clients 
Opened up communication with 
OPPT about future collaborations 
with TSCA for continued support of 
computational toxicology data 
Develop knowledge of one's individual 
strengths and challenges, as well as 
mechanisms for continued personal and 
professional development 
Discovered my expertise has been 
shifted towards the computer 
science field and need to expand my 
knowledge about regulatory 
toxicology 
Program Planning Identify needed resources for public health programs or research 
Learned more about the data used 
for risk characterizations and 
chemical safety decisions 
Systems Thinking 
Identify characteristics of a system 
Worked across multiple offices 
within a highly structured agency, 
which is a system 
Respond to identified public health needs 
within their appropriate contextual setting 
Attended meetings that addressed 
the needs of different communities: 
scientists and the general public 
Environmental 
Sciences 
Describe federal and state regulatory programs, 
guidelines and authorities that control 
environmental health issues 
Reviewed TSCA methodologies 
with those who collect TSCA data 
Specify current environmental risk assessment 
methods 
Specify approaches for assessing, preventing 
and controlling environmental hazards that 
pose risks to human health and safety 
 
Table 4 : Competencies Met for Practicum 
The practicum is a partial requirement for completion of a Master of Science in Public 
Health. The competencies met for the practicum along with brief descriptions of how 
each competency is completed are described in this table.   
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